[moc::"[[MOC Oral Cavity]]"]
>[!title]
> NRG-HN006 [About](https://www.nrgoncology.org/Home/News/Post/sentinel-lymph-node-biopsy-in-early-stage-oral-cavity-disease-nrg-hn006), [NCT04333537](https://clinicaltrials.gov/ct2/show/NCT04333537): Phase II/III. 

>[!intervention] 
> Negative baseline PET/CT -> SLNB vs. END.

# study

![[img_HN006_schema.png#invert]]

## Indications
### AdjRT: 
1. Primary site: PNI, LVSI, pT3+, close SM (<5mm)
2. Nodal features: N2+ (consider for N1+)
### AdjCCRT: 
1. Primary site: +SM
2. Nodal features: ENE

## Treatment
### 66 Gy
- Optional
- ECE, positive SM
### 60 Gy
- Sx bed, pN+ levels
- CTV = ^ + 5-10mm
### 56 Gy
- elective neck (dependent on sub site)

| subsite                    | elective levels (optional) | laterality    |
| -------------------------- | -------------------------- | ------------- |
| Tongue (>1cm from midline) | I , II, III, IV, (V)       | Ipsi          |
| Tongue (<1cm from midline) | I , II, III, IV, (V)       | Bi            |
| FOM                        | I , II, III, IV, (V)       | Bi            |
| RMT                        | IB, II, III, IV, (V)       | Ipsi (if lat) |
| Buccal mucosa              | IB, II, III, IV, (V)       | Ipsi (if lat) |
| Hard palate                | IB, II, III, IV, (V)       | Bi            | 

# results
Pending. Estimated completion 2036


>[!summary] 
> If you have a negative baseline PET, can you get away with just a SNLBx?
> - [[Senti-MERORL (ELND vs SLND)|Senti-MERORL]] already sorta looked at this, but HN006 is currently accruing to more definitively answer the question. 
> - This study takes patients with a negative PET and randomizes them to SNLBx or full END. Afterwards, the patients get RT if they have PNI, LVSI, pT3+, pN+, or close margins. You'd add chemo for +SM or ENE (per [[22931-9501 combined (adjRT Â± chemo)|22931/9501]])
>^summary


![[08_HN006.pdf]]